PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding PMV Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 99 | 1 | 93 | −5 |
| Shares | 42.7M | 2.50K | 40.5M | −2.25M (−5.3%) |
| Value | $72.7M | $4.00K | $65.6M | −$7.10M (−9.8%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sio Capital Management, LLC | 2,708,408 | $4.39M | 1.65% |
| Exome Asset Management LLC | 358,400 | $580.6K | 0.52% |
| Aldebaran Capital, LLC | 351,243 | $569.0K | 0.53% |
| RBF Capital, LLC | 253,361 | $410.4K | 0.02% |
| Centiva Capital, LP | 76,963 | $124.7K | 0.01% |
| Qube Research & Technologies Ltd | 71,701 | $116.2K | 0.00% |
| Evoke Wealth, LLC | 63,233 | $102.4K | 0.15% |
| Point72 Asia (Singapore) Pte. Ltd. | 62,634 | $101.5K | 0.02% |
| Squarepoint Ops LLC | 51,124 | $82.8K | 0.00% |
| Paloma Partners Management Co | 35,069 | $56.8K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 31,749 | $51.4K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 21,151 | $34.3K | 0.00% |
| Point72 (DIFC) Ltd | 14,545 | $23.6K | 0.00% |
| Jump Financial, LLC | 11,873 | $19.2K | 0.00% |
| HRT Financial LP | 12,014 | $19.0K | 0.00% |
| Russell Investments Group, Ltd. | 4,711 | $7.63K | 0.00% |
| Catalyst Funds Management Pty Ltd | 2,100 | $3.40K | 0.00% |
| Macquarie Group Ltd | 2,077 | $3.37K | 0.00% |
| Nordwand Advisors, LLC | 2,000 | $3.24K | 0.00% |
| Capital Advisors, Ltd. LLC | 322 | $1.00K | 0.00% |
| Nisa Investment Advisors, LLC | 65 | $105 | 0.00% |
Sold out (26)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Cutler Group LP | 2,500 | $4.00K |